- Oxidation of an antitumor drug ellipticine by peroxidases2005 | Faculty of Science
- Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P4502005 | Faculty of Science
- Evidence for cytochrome P450-dependent covalent binding of antitumor drug ellipticine to DNA2000 | Faculty of Science
- Evidence for cytochrome P450-dependent covalent binding of antitumor drug ellipticine to DNA2000 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Cardiotoxicity of antitumor drugs in ovarian cancer patients2015 | Faculty of Medicine in Hradec Králové
- Poly-ethylene glycol)-grafted polyglutamines as self-structuring carriers for antitumor drug delivery2000 | First Faculty of Medicine
- Doxorubicin interactions with bovine serum albumin revealed by microdialysis with on-line laser-induced fluorescence detection at subpicogram level2015 | Faculty of Science, Second Faculty of Medicine
- Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: Synthesis, structure, electrochemistry, and cytotoxicity2008 | Faculty of Science
- Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the P-32-postlabeling technique2012 | Second Faculty of Medicine
- The interaction of antitumor active vanadocene dichloride with sulfur-containing amino acids2007 | Faculty of Science
- Water-soluble arene ruthenium complexes containing pyridinethiolato ligands: Synthesis, molecular structure, redox properties and anticancer activity of the cations [(eta(6)-arene)Ru(p-SC5H4NH)(3)](2+)2008 | Faculty of Science
- The Same Drug but a Different Mechanism of Action: Comparison of Free Doxorubicin with Two Different N-(2-Hydroxypropyl)methacrylamide Copolymer-Bound Doxorubicin Conjugates in EL-4 Cancer Cell Line2007 | First Faculty of Medicine
- HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents2009 | Central Library of Charles University
- DNA adducts are formed from ellipticine and ellipticine-human serum albumin (Elli-HSA) in cells transfected with cytochrome P4502000 | Faculty of Science
- DNA adducts are formed from ellipticine and ellipticine-human serum albumin (Elli-HSA) in cells transfected with cytochrome P4502000 | First Faculty of Medicine, Faculty of Mathematics and Physics
- HPLC methods for determination of two novel thiosemicarbazone anti-cancer drugs (N4mT and Dp44mT) in plasma and their application to in vitro plasma stability of these agents2009 | Faculty of Pharmacy in Hradec Králové
- New treatment options and therapeutic strategies in oncology.2010 | First Faculty of Medicine
- New treatment options and therapeutic strategies in oncology.2010 | Publication without faculty affiliation
- Brief history of chemotherapy2013 | First Faculty of Medicine
- Pharmaceutical agent for the treatment of malignant melanomaPublication without faculty affiliation
- Immunotherapy in non-melanoma skin cancer +12022 | First Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Faculty of Science, First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- The Synergistic Effects of DNA-Targeted Chemotherapeutics and Histone Deacetylase Inhibitors As Therapeutic Strategies for Cancer Treatment2012 | Second Faculty of Medicine
- Possibilities of using new (direct) oral anticoagulants in oncology2020 | Faculty of Medicine in Pilsen
- Study of Metallothionein Levels in the Serum of Patients with Malignant Tumour2023 | Central Library of Charles University, First Faculty of Medicine, Second Faculty of Medicine
- Embryotoxicity of cisplatin and a cisplatin-procaine complex (DPR) studied in chick embryo2002 | Third Faculty of Medicine
- Natural compounds and combination therapy in colorectal cancer treatment2018 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Hydrogel implants for transscleral drug delivery for retinoblastoma treatment2019 | Second Faculty of Medicine